Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TWKS
2076
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $1.98M | ﹤0.01% |
194,300
-141,400
| -42% | -$1.31M |
|
2077
Theravance Biopharma
TBPH
$876M
| $1.98M | ﹤0.01% |
176,426
+24,249
| +16% | +$255K |
|
2078
State Street SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.27B
| $1.98M | ﹤0.01% |
+96,200
| New | +$1.89M |
|
2079
Chemung Financial Corp
CHMG
$399M
| $1.95M | ﹤0.01% |
42,591
-831
| -2% | -$37.1K |
|
2080
NovaGold Resources
NG
$3.02B
| $1.95M | ﹤0.01% |
326,769
+252,466
| +340% | +$1.35M |
|
2081
Lantronix
LTRX
$263M
| $1.95M | ﹤0.01% |
452,094
-25,700
| -5% | -$121K |
|
2082
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
| $1.95M | ﹤0.01% |
43,400
+36,400
| +520% | +$1.62M |
|
2083
Dimensional National Municipal Bond ETF
DFNM
$2.24B
| $1.95M | ﹤0.01% |
+40,800
| New | +$1.93M |
|
2084
Expensify
EXFY
$195M
| $1.95M | ﹤0.01% |
220,600
+36,800
| +20% | +$412K |
|
2085
Northrim BanCorp
NRIM
$600M
| $1.95M | ﹤0.01% |
142,716
-32,524
| -19% | -$410K |
|
|
DCBO
2086
Docebo
DCBO
$517M
| $1.94M | ﹤0.01% |
58,700
-63,000
| -52% | -$1.89M |
|
2087
Astrana Health
ASTH
$1.78B
| $1.94M | ﹤0.01% |
+65,700
| New | +$2.11M |
|
2088
SiriusPoint
SPNT
$2.74B
| $1.94M | ﹤0.01% |
329,287
-223,800
| -40% | -$1.32M |
|
2089
NMI Holdings
NMIH
$3.38B
| $1.94M | ﹤0.01% |
92,900
+36,600
| +65% | +$767K |
|
|
ALBO
2090
DELISTED
Albireo Pharma Inc
ALBO
| $1.94M | ﹤0.01% |
89,683
-50,000
| -36% | -$1.06M |
|
2091
Wheels Up
UP
$208M
| $1.94M | ﹤0.01% |
9,401
+321
| +4% | +$82.8K |
|
2092
AMES National
ATLO
$277M
| $1.93M | ﹤0.01% |
81,684
+8,255
| +11% | +$188K |
|
2093
iShares MSCI Mexico ETF
EWW
$1.97B
| $1.93M | ﹤0.01% |
+38,992
| New | +$1.96M |
|
2094
Simply Good Foods
SMPL
$989M
| $1.93M | ﹤0.01% |
+50,700
| New | +$1.87M |
|
2095
Epsilon Energy
EPSN
$165M
| $1.93M | ﹤0.01% |
290,600
-3,100
| -1% | -$21.4K |
|
2096
iShares MSCI Saudi Arabia ETF
KSA
$624M
| $1.92M | ﹤0.01% |
+51,000
| New | +$2.06M |
|
2097
Plexus
PLXS
$7.35B
| $1.92M | ﹤0.01% |
18,693
+8,500
| +83% | +$859K |
|
2098
The Joint Corp
JYNT
$119M
| $1.91M | ﹤0.01% |
136,778
+7,700
| +6% | +$119K |
|
2099
Kirby Corp
KEX
$7.01B
| $1.91M | ﹤0.01% |
+29,600
| New | +$1.98M |
|
2100
Schwab Emerging Markets Equity ETF
SCHE
$12.8B
| $1.9M | ﹤0.01% |
80,200
+10,200
| +15% | +$237K |
|
Similar funds
Renaissance Technologies's Q4 2022 Portfolio in Review
As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
- Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
- Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.